News

Venture Challenge Summer 2021: Meet the Teams!

Last week, the Venture Challenge Summer 2021 kicked off with innovative Life Sciences & Health startups participating in the first bootcamp. The participating teams worked on shaping their value propositions, vision and competitive differentiation to translate their idea into a solid business case.
Groepsfoto

Venture Challenge alumnus Scope wins AtlasInvest Start-Up Award

Scope Biosciences was announced as one of the two winners of the AtlasInvest Entrepreneurship Grant during the F&A Next 
Scope wins AtlasInvest Entrepreneurship Grant

Want to further develop your business skills? Then register for the TAP BioBusiness training programme

Are you a future BioBusiness leader in Life Sciences & Health? Register now for the TAP BioBusiness training programme and benefit from the early bird fee until 1 June 2021!
TAP Early Bird

Venture Challenge Fall 2021 open for applications!

Today the applications for the 26th edition of the Venture Challenge has opened!
Venture Challenge is open for applications

Venture Challenge winner SeraNovo enters into license agreement with Graviton

SeraNovo BV is pleased to announce the closing of a License Agreement with Graviton Bioscience Corporation (Graviton), a biopharmaceutical company engaged in the research and development of small molecules in the fields of oncology and neuroscience.
SeraNovo Graviton

Venture Challenge alumnus OcellO acquired by Crown Biosciences

Crown Bioscience (CrownBio), a JSR Life Sciences company and leader in preclinical services that help biopharmaceutical companies accelerate new drug development programs, has acquired OcellO B.V., a privately owned contract research organization located in the Netherlands.
Ocello

AVATAR Zoo announced as winner of the Proefdiervrij Venture Challenge

Stichting Proefdiervrij wants to increase and accelerate the impact of non-animal research on the use of laboratory animals and has therefore organised the first Animal-free Venture Challenge.
AVATAR Zoo announced as winner of the Proefdiervrij Venture Challenge

Khondrion announces first patients dosed in 6-month paediatric Phase II study of sonlicromanol for mitochondrial diseases

Study will examine the pharmacokinetics, safety and efficacy of sonlicromanol, one of the most advanced disease-modifying drug candidates in development for mitochondrial disease
Khondrion announces first patients dosed in 6-month paediatric Phase II study of sonlicromanol for mitochondrial diseases

MedicalVR technology used for performing complex tumor removal

Next to lung, liver or heart surgeries, MedicalVR technology can be implemented in a multidisciplinary setting of plastic & reconstructive, oncologic and cardiotho
MedicalVR technology used for performing complex turf removal

Toxys' ToxTracker performed very well in large PoC study by Proctor & Gamble

A proof of concept study of 18 chemicals comparing in vitro micronucleus, ToxTracker and genomics-based methods
Toxys' ToxTracker performed very well in large PoC study by Proctor & Gamble